$PATH

Ramani Hitesh sold $831K of PATH

Ramani Hitesh (Chief Accounting Officer) sold 50,000 shares of UiPath, Inc. (PATH) at an average of $16.62 ($16.50–$16.75, $0.83M total) across 2 trades over 2026-08-13 to 2026-08-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Ramani Hitesh
Published Aug 14, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 8:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PATH
Neutral
high confidence
Mentioned
$PATH
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PATHNeutralLow
01

Why it matters

The only new information is the disclosed sale size, timing, and price range, plus confirmation that it was executed under a pre-arranged 10b5-1 plan. No operational or financial guidance changes are included.

02

Market read

Traders may note insider selling, but the 10b5-1 structure and lack of fundamental updates make this more of a sentiment datapoint than a catalyst.

03

What to watch

The filing does not indicate whether additional sales occurred outside the disclosed window, nor does it provide context on total planned sales or remaining tranche size.

Relevance 4/10Novelty 5/10Timing: Filed on 2026-08-14 after two sales on 2026-08-13 and 2026-08-14.

Background

The article is a SEC Form 4 insider transaction disclosure for UiPath, Inc. (PATH) by Chief Accounting Officer Ramani Hitesh.

Company-level read

Ticker impact

$PATHNeutralHigh confidence
Context

UiPath Form 4 shows CFO Ramani Hitesh sold 50,000 shares in open-market trades at about $16.50 to $16.75 (10b5-1).

Expected impact

Low near-term impact; any reaction is likely limited to short-lived sentiment rather than a durable repricing.

Evidence & confidence

The filing is a routine Form 4 open-market sale by an officer, explicitly under a pre-arranged 10b5-1 plan, with no accompanying guidance, operational change, or regulatory/legal event disclosed.

Market effects

Minimal. Insider selling under 10b5-1 in a single software name does not materially change sector fundamentals.

Minimal.

Minimal.

Counterpoint

Because the trades are under a 10b5-1 plan, the sale may reflect scheduled liquidity rather than bearish expectations, so any negative read-through may be overstated.

Key entities

  • UiPath, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Ramani Hitesh

    Chief Accounting Officer who sold shares via open-market trades under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PATHMed

UiPath Stock Steadies As AI Agent Push Meets Wall Street Caution

UiPath Inc. (NYSE: PATH) shares rose 4.5% on September 30, 2026, driven by strong enterprise automation adoption and AI growth sentiment. The stock has been trading between $12.60 and $13.00, showing signs of stabilization. UiPath reported quarterly revenue of $410.3M, gross margin of 82.6%, and net income of $36.1M. The company is shifting focus to AI agents and orchestration, with aggressive long-term targets.

$PATHMed

A Philippine Telecom’s AI Makeover Tests UiPath’s (PATH) Pitch

UiPath (PATH) announced that PLDT, a Philippine telecom, scaled its use of UiPath's AI platform, improving efficiency and saving thousands of work hours. PATH reported Q2 2027 revenue of $410M, up 13% YoY, and annual recurring revenue of $1.938B, up 12%. The company also introduced new products and reshuffled its executive team. PATH's net new ARR was $37M, and GAAP operating income was $32M, below non-GAAP figures.